An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Condition(s):Biliary AtresiaLast Updated:March 28, 2024Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Biliary AtresiaLast Updated:March 28, 2024Enrolling by invitation
Condition(s):Biliary AtresiaLast Updated:March 26, 2024Completed
Condition(s):BA – Biliary AtresiaLast Updated:June 23, 2023Completed
Condition(s):Biliary AtresiaLast Updated:February 5, 2010Completed
Condition(s):Biliary AtresiaLast Updated:October 1, 2019Completed
Condition(s):Biliary AtresiaLast Updated:September 8, 2023Recruiting
Condition(s):Biliary AtresiaLast Updated:December 5, 2023Recruiting
Condition(s):Biliary AtresiaLast Updated:March 28, 2024Recruiting
Condition(s):Biliary AtresiaLast Updated:September 13, 2023Recruiting
Condition(s):Biliary AtresiaLast Updated:January 11, 2024Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.